QCM
MRNA icon

Quantinno Capital Management’s Moderna MRNA Stock Holding History

Quantinno Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Buy
219,606
+51,529
+31% +$2.67M 0.02% 816
2026
Q1 		$8.54M Buy
168,077
+71,888
+75% +$3.35M 0.01% 933
2025
Q4 		$2.84M Sell
96,189
-165
-0.2% -$4.48K 0.01% 1246
2025
Q3 		$2.49M Sell
96,354
-77,717
-45% -$2.17M 0.01% 1154
2025
Q2 		$4.8M Buy
174,071
+90,722
+109% +$2.39M 0.02% 828
2025
Q1 		$2.36M Buy
83,349
+12,051
+17% +$428K 0.02% 928
2024
Q4 		$2.96M Buy
71,298
+61,892
+658% +$2.96M 0.03% 688
2024
Q3 		$629K Sell
9,406
-56,562
-86% -$5.19M 0.01% 1065
2024
Q2 		$7.83M Buy
65,968
+41,041
+165% +$5.19M 0.14% 116
2024
Q1 		$2.66M Buy
24,927
+5,363
+27% +$541K 0.06% 398
2023
Q4 		$1.95M Buy
19,564
+15,673
+403% +$1.32M 0.07% 382
2023
Q3 		$402K Sell
3,891
-2,268
-37% -$253K 0.02% 795
2023
Q2 		$748K Sell
6,159
-1,403
-19% -$187K 0.04% 498
2023
Q1 		$1.16M Buy
7,562
+238
+3% +$39.3K 0.08% 334
2022
Q4 		$1.32M Buy
7,324
+2,937
+67% +$480K 0.1% 296
2022
Q3 		$519K Buy
4,387
+401
+10% +$60.8K 0.07% 360
2022
Q2 		$569K Buy
3,986
+67
+2% +$9.58K 0.08% 306
2022
Q1 		$675K Buy
+3,919
New +$660K 0.1% 242

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Quantinno Capital Management's MRNA Position: Q2 2026 in Review

Quantinno Capital Management increased its Moderna (MRNA) stake by 31% in Q2 2026, buying an estimated $2.67M and bringing the position to 219,606 shares worth $15.4M. The position accounts for 0.02% of the portfolio, ranked #816.

Quantinno Capital Management first reported a position in MRNA in Q1 2022 and has held it in 18 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Quantinno Capital Management held 219,606 shares of Moderna worth $15.4M as of Q2 2026.
  • Quantinno Capital Management bought 51,529 Moderna shares in Q2 2026, an estimated $2.67M.
  • Moderna made up 0.02% of Quantinno Capital Management's portfolio in Q2 2026, its #816 holding.
  • Quantinno Capital Management first reported a position in Moderna in Q1 2022 and has held it in 18 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.